by EmVenio | Apr 15, 2024 | Blog
The recent World Vaccine Congress proved to be a pivotal moment for the industry, marking achievements, recognition, and inspiring discussions that propel us forward in the realm of clinical trials and vaccine development. As we gather our thoughts and reflections,...
by Christina Babu | Aug 1, 2023 | Press Release
Please join us in welcoming Dr. Stephen Blank, M.D., and Dr. Suzanne Swan, M.D., who’ve joined our team as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible...
by EmVenio | Apr 25, 2023 | Blog
EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in...
by EmVenio | Mar 14, 2023 | Blog
EmVenio president Thad Wolfram spoke to CenterWatch about our innovative approach to expand access and diversity in clinical trials through our fleet of mobile community research sites. Thad discussed how EmVenio was formed and its mission behind the work we do. Read...
by EmVenio | Feb 15, 2023 | Press Release
Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA, February 15, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a...
